Hindbrain catecholamine neurons modulate the growth hormone but not the feeding response to ghrelin.
The gastrointestinal peptide, ghrelin, elicits feeding and secretion when administered systemically or centrally. Previous studies have suggested that hypothalamic projections of hindbrain catecholamine neurons are involved in both of these actions of ghrelin. The purpose of this study was to further assess the role of hindbrain catecholamine neurons in ghrelin-induced feeding and GH secretion and to determine the anatomical distribution of the catecholamine neurons involved. We lesioned noradrenergic and adrenergic neurons that innervate the medial hypothalamus by microinjecting the retrogradely transported immunotoxin, saporin (SAP) conjugated to antidopamine-beta-hydroxylase (DSAP) into the paraventricular nucleus of the hypothalamus. Controls were injected with unconjugated SAP. We found that the DSAP lesion did not impair the feeding response to central or peripheral ghrelin administration, indicating that these neurons are not required for ghrelin's orexigenic effect. However, the GH response to ghrelin was prolonged significantly in DSAP-lesioned rats. We also found that expression of Fos, an indicator of neuronal activation, was significantly enhanced over baseline levels in A1, A1/C1, C1, and A5 cell groups after ghrelin treatment and in A1, A1/C1, and A5 cell groups after GH treatment. The similar pattern of Fos expression in catecholamine cell groups after GH and ghrelin and the prolonged GH secretion in response to ghrelin in DSAP rats together suggest that activation of hindbrain catecholamine neurons by ghrelin or GH could be a component of a negative feedback response controlling GH levels.
Emanuel
Alan J
AJ
Programs in Neuroscience, Washington State University, Pullman, WA 99164-6520, USA.
Ritter
Sue
S
D000818:Animals; D002395:Catecholamines / Q000378:metabolism*; D004435:Eating / Q000187:drug effects; D005247:Feeding Behavior / Q000187:drug effects*; D054439:Ghrelin / Q000494:pharmacology*; D013006:Growth Hormone / Q000378:metabolism* / Q000494:pharmacology; D007031:Hypothalamus / Q000187:drug effects / Q000378:metabolism; D007150:Immunohistochemistry; D008297:Male; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D012249:Rhombencephalon / Q000166:cytology* / Q000187:drug effects; D054789:Ribosome Inactivating Proteins, Type 1 / Q000737:chemistry / Q000494:pharmacology; D000076985:Saporins
D002395:Catecholamines; D054439:Ghrelin; D054789:Ribosome Inactivating Proteins, Type 1; D013006:Growth Hormone; D000076985:Saporins
Biochem Biophys Res Commun. 2000 Aug 28;275(2):477-80
10964690
Peptides. 2003 Jun;24(6):919-23
12948845
Science. 1996 Aug 16;273(5277):974-7
8688086
Brain Res. 2008 Jul 7;1218:151-7
18514175
Brain Res. 1994 Mar 28;641(1):111-20
8019836
Endocrinology. 2000 Nov;141(11):4255-61
11089560
Physiol Rev. 2005 Apr;85(2):495-522
15788704
J Clin Endocrinol Metab. 2005 Aug;90(8):4521-4
15914532
Diabetes. 2001 Nov;50(11):2540-7
11679432
Nature. 2001 Jan 11;409(6817):194-8
11196643
Diabetes. 2001 Nov;50(11):2438-43
11679419
Cell Metab. 2006 Oct;4(4):323-31
17011505
J Clin Endocrinol Metab. 2001 Dec;86(12):5992
11739476
Neuroscience. 1995 Jan;64(2):477-505
7700534
Physiol Behav. 2007 Apr 23;90(5):744-50
17289093
Nature. 1999 Dec 9;402(6762):656-60
10604470
Neuron. 2003 Feb 20;37(4):649-61
12597862
Neuroendocrinology. 1993 May;57(5):921-7
8105398
J Neuroendocrinol. 1993 Apr;5(2):145-50
8097943
Endocrinology. 2005 Aug;146(8):3518-25
15890776
Brain Res. 1982 Nov;257(3):275-325
6756545
Biochem Biophys Res Commun. 2001 Mar;281(5):1220-5
11243865
Physiol Behav. 2004 Jul;81(5):719-33
15234177
J Clin Invest. 2009 Nov;119(11):3189-202
19884662
Neuroendocrinology. 1996 Aug;64(2):131-8
8857607
Prog Brain Res. 1983;60:19-29
6198687
Eur J Endocrinol. 2004 Oct;151(4):447-50
15476443
Peptides. 2005 Nov;26(11):2274-9
16137788
Neuroreport. 2004 Jun 7;15(8):1365-7
15167567
J Nutr. 2005 May;135(5):1320-5
15867333
Neuroendocrinology. 1993 Apr;57(4):687-92
8396221
Brain Res. 1998 Sep 14;805(1-2):41-54
9733914
Endocrinology. 2003 Mar;144(3):967-74
12586774
Vitam Horm. 2008;77:47-88
17983853
Endocrinology. 2005 Mar;146(3):1179-91
15604214
Curr Neuropharmacol. 2009 Mar;7(1):37-49
19721816
Gastroenterology. 2002 Oct;123(4):1120-8
12360474
Ann N Y Acad Sci. 2009 Apr;1163:137-53
19456335
Diabetes. 2003 Sep;52(9):2260-5
12941764
Endocrinology. 2005 Jun;146(6):2510-6
15774556
J Neurosci. 2006 Oct 25;26(43):11052-60
17065447
Brain Res Bull. 1988 Dec;21(6):905-12
3224284
Regul Pept. 2003 Mar 28;111(1-3):161-7
12609764
Endocrinology. 2003 Jan;144(1):75-83
12488332
Regul Pept. 2001 Jun 15;99(2-3):141-50
11384775
J Comp Neurol. 1985 Mar 15;233(3):308-32
2858497
Circulation. 2001 Oct 23;104(17):2034-8
11673342
Am J Physiol Gastrointest Liver Physiol. 2006 Jun;290(6):G1350-8
16469825
Neuroendocrinology. 1994 Jan;59(1):29-34
7908421
J Neurosci. 2009 Jan 7;29(1):280-7
19129404
J Comp Neurol. 2001 Apr 2;432(2):197-216
11241386
Gut. 2003 Jul;52(7):947-52
12801949
Endocrinology. 2003 Apr;144(4):1357-67
12639919
Neurosci Biobehav Rev. 1988 Summer;12(2):101-9
2845312
Peptides. 2007 Feb;28(2):214-25
17194499